World's Best Scientists 2026 revealed!
Giampaolo Tortora

Giampaolo Tortora

D-Index & Metrics

Medicine

D-Index
97
Citations
56723
World Ranking
9077
National Ranking
313

Overview

Giampaolo Tortora is affiliated with the University of Verona in Italy and focuses their research on the field of Medicine, with a strong specialization in Oncology. Their work spans diverse subfields such as Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery, and Molecular Biology.

Their research covers several key topics including:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Renal Cell Carcinoma Treatment
  • Genetic Factors in Colorectal Cancer
  • Cancer Treatment and Pharmacology

Giampaolo Tortora has contributed to publications in multiple journals, with frequent appearances in:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Cancers
  • ESMO Open
  • Frontiers in Oncology

Recent published papers featuring their work or collaboration include:

  • Gut microbiome, big data and machine learning to promote precision medicine for cancer, 2020, Nature Reviews Gastroenterology & Hepatology
  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial, 2020, The Lancet Oncology
  • Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial, 2022, The Lancet Oncology
  • Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer, 2022, Journal of Clinical Oncology
  • Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma, 2020, Nature Communications

Their frequent coauthors include:

  • Emilio Bria
  • Lisa Salvatore
  • Maria Bensi
  • Roberto Iacovelli
  • Armando Orlandi

Best Publications

  • Genomic analyses identify molecular subtypes of pancreatic cancer

    Bailey P;Chang Dk;Nones K;Nones K;Johns Al

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Whole genomes redefine the mutational landscape of pancreatic cancer.

    Nicola Waddell;Marina Pajic;Ann Marie Patch;David K. Chang

  • EGFR Antagonists in Cancer Treatment

    Fortunato Ciardiello;Giampaolo Tortora

  • Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

    Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras

  • Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    Talia Golan;Pascal Hammel;Michele Reni;Eric Van Cutsem

  • A NOVEL APPROACH IN THE TREATMENT OF CANCER: TARGETING THE EPIDERMAL GROWTH FACTOR RECEPTOR

    Fortunato Ciardiello;Giampaolo Tortora

  • Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human Cancer Cells by ZD-1839 (Iressa), an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor

    Ciardiello F;Caputo R;Bianco R;Damiano

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Whole-genome landscape of pancreatic neuroendocrine tumours

    Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo

  • Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor,

    Fortunato Ciardiello;Rosa Caputo;Roberto Bianco;Vincenzo Damiano

  • ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.

    Francesca Carlomagno;Donata Vitagliano;Teresa Guida;Fortunato Ciardiello

  • Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

    Roberto Ferrara;Laura Mezquita;Matthieu Texier;Jihene Lahmar

  • nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

    David Goldstein;Robert Hassan El-Maraghi;Pascal Hammel;Volker Heinemann

  • Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

    Yuchen Jiao;Timothy M Pawlik;Robert A Anders;Florin M Selaru

  • Expression of Epidermal Growth Factor Receptor Correlates with Disease Relapse and Progression to Androgen-independence in Human Prostate Cancer

    Giuseppe Di Lorenzo;Giampaolo Tortora;Francesco P. D’Armiento;Gaetano De Rosa

  • A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

    J. Mateo;D. Chakravarty;R. Dienstmann;S. Jezdic

  • Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.

    F. Ciardiello;R. Bianco;V. Damiano;G. Fontanini

  • Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase

    Fortunato Ciardiello;Rosa Caputo;Vincenzo Damiano;Roberta Caputo

  • Expression of epidermal growth factor receptor (EGFR) correlates with disease relapse and progression to androgen-indepedence in human prostate cancer

    G Di Lorenzo;Giampaolo Tortora;Fp Armiento

Frequent Co-Authors

Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
Aldo Scarpa
Aldo Scarpa University of Verona
Stefano Pepe
Stefano Pepe University of Salerno
Michele Milella
Michele Milella University of Verona
Guido Martignoni
Guido Martignoni University of Verona
Yoon S. Cho-Chung
Yoon S. Cho-Chung National Institutes of Health
Diana Giannarelli
Diana Giannarelli Sapienza University of Rome
Sabino De Placido
Sabino De Placido University of Naples Federico II
Gabriella Fontanini
Gabriella Fontanini University of Pisa
Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in medicine or looking to advance their healthcare qualifications, a variety of online degree options are available in the USA. Online programs provide flexibility, making it easier for students and working professionals to upskill or retrain while managing other responsibilities.

Nursing is a particularly popular pathway. Prospective nurse practitioners can explore options at the cheapest np school programs to reduce education costs while maintaining quality. For those just starting out, enrolling in online nursing courses can be a practical first step.

Career advancement is also possible through doctoral studies. Nurses interested in research or leadership should consider enrolling in online phd programs nursing for greater specialization and new opportunities.

Additionally, registered nurses can upgrade their credentials and boost their career prospects by transitioning through an RN to BSN. Understanding the average cost of rn to bsn programs is essential to making an informed decision about further study.

Best Scientists Citing Giampaolo Tortora

Trending Scientists

Recently Published Articles